Celebrating a year of scientific creativity

We recently launched the first edition of our annual progress magazine - Discover: a year of scientific creativity. 
Discover celebrates how our teams are coming together, thinking differently and driving progress against some of cancer's toughest challenges.
Read Discover

Collaboration and community

"We’ve unearthed a new way to think about cancer”

Challenge: tissue specificity

SPECIFICANCER’s latest study in Science identifies a new way that cancers avoid discovery and destruction by the immune system, information which could lead to more effective therapies.
Read more

New thinking on the process of ageing

Challenge: unusual mutation patterns

In Nature Genetics, the Mutographs team challenges what we thought we knew about ageing, revealing that healthy cells can tolerate many more mutations that previously assumed. 
Read more

The mystery surrounding oesophageal cancer’s triggers deepens

Challenge: unusual mutation patterns

Unexpected findings from the Mutographs team add a new piece to the complex puzzle surrounding the oesophageal cancer risk – although incidence varies dramatically around the world, these differences can’t be explained by a mutational signature.

Postdoc Sarah Moody discusses the surprising findings in an article for our news hub. We also spoke to team lead Mike Stratton on where this discovery could take the team next - watch here.

We were delighted to see these findings covered in the media. Congrats also to the team on securing the front cover of this month's Nature Genetics!

Read more

"We can all be agents of change"

In October, we held our first Future Leaders Conference - a chance for the early career members of our community to come together virtually, discuss their work and focus on professional development.

The event was powered by a steering committee of postdoctoral fellows and PhD students, including STORMing Cancer's Elee Shimshoni. Check out her key learnings. 
Read more

Why virtual reality is the future

Challenge: 3D tumour mapping

In response to our 3D tumour mapping challenge, the IMAXT team is using VR mechanics to analyse tumour data in a new and immersive context.

Check out this short film from Columbia Cancer Research showcasing IMAXT’s tech in action, featuring members of the team  – co-investigators Simon Tavaré and Owen Harris, and postdoctoral researcher Ignacio Vazquez-Garcia.
Watch the video
Twitter
LinkedIn
Website
Copyright © 2021 Cancer Grand Challenges, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
Cancer Grand Challenges
2 Redman Place
London, London E20 1JQ
United Kingdom

Add us to your address book


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.